• linkedin
  • Increase Font
  • Sharebar

    Product Update: HIFU cleared, compact catheter launched




    SonaCare Medical receives FDA clearance for HIFU prostate device

    Charlotte, NC—SonaCare Medical, LLC received FDA clearance to market the Sonablate 450 in the U.S. for the ablation of prostate tissue. Sonablate uses high-intensity ultrasound (HIFU) to deliver precise and focused ablation, according to SonaCare Medical. It’s powered by A3 Technology, which allows physicians to aim energy at specific tissue using integrated ultrasound imaging and sophisticated planning tools; ablate targeted tissue with HIFU ablation that provides pinpoint accuracy while sparing untargeted tissue; and analyze procedure results using real-time ultrasound imaging along with advanced tissue change monitoring software. SonaCare Medical was expected to begin U.S. distribution in October.  

    For more information, visit www.SonaCareMedical.com.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results